Apolipoproteins and the risk of giant cell arteritis—a nested case–control study

Table 4 Potential predictors of giant cell arteritis in multivariate analyses, adjusted analyses

	Adjusted for BMI		Adjusted for physical activity		Adjusted for BMI and physical activity
	OR	95% CI	OR	95% CI	OR	95% CI
All
ApoA1	1.50	1.12–2.02	1.57	1.17–2.10	1.48	1.09–1.99
ApoB	1.01	0.76–1.35	1.04	0.78–1.40	1.08	0.81–1.46
ApoB/ApoA1	0.84	0.62–1.13	0.83	0.62–1.12	0.90	0.66–1.22
Women
ApoA1	1.66	1.19–2.31	1.81	1.31–2.51	1.67	1.20–2.34
ApoB	1.18	0.86–1.62	1.15	0.83–1.58	1.22	0.88–1.69
ApoB/ApoA1	0.90	0.63–1.27	0.92	0.58–1.15	0.91	0.64–1.30
Men
ApoA1	0.90	0.44–1.84	0.71	0.21–1.59	0.70	0.31–1.61
ApoB	0.47	0.21–1.07	0.61	0.28–1.33	0.60	0.27–1.33
ApoB/ApoA1	0.70	0.37–1.32	0.87	0.47–1.63	0.86	0.46–1.64

All odds rations are per standard deviation: ApoA1 25.5 mg/dL, ApoB 27.1 mg/dL, ApoB/ApoA1 0.22
BMI body mass index, OR odds ratio, CI confidence interval

ISSN: 1478-6362